Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Cefazolin-AFT
Active Ingredient: Cefazolin sodium 1.08g equivalent to cefazolin 1g
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Qilu Pharmaceutical Co Limited, Shandong Province, China
Product: Cefazolin-AFT
Active Ingredient: Cefazolin sodium 540mg equivalent to Cefazolin 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Qilu Pharmaceutical Co Limited, Shandong Province, China
Product: Imodium Zapid
Active Ingredient: Loperamide hydrochloride 2mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Catalent UK Swindon Zydis Limited, Wiltshire, United Kingdom
Dated this 22nd day of July 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).